Evidence of Harms
Two kinds of harms or complications may result from screening. Direct harms may result from complications of liver biopsy done as part of the diagnostic workup. Such complications are reported in 0.06% to 0.32% of patients, and typically occur within the first few hours after the biopsy. Complications include hemorrhage, bile peritonitis, penetration of viscera, and pneumothorax. Rarely, death occurs as a direct result of liver biopsy (0.009%–0.12%). About one third of patients experience pain at the site of entry, in the right upper quadrant, or in the right shoulder.[1] Needle aspiration cytology and liver biopsy are rarely associated with needle-track implantation of malignant cells. Lead-time bias (earlier diagnosis in the natural
history of HCC rather than improved survival from earlier diagnosis and
treatment), length bias (earlier detection of slower-growing and less
aggressive tumors through screening), and/or overdiagnosis of HCC (detection of
tumors that will not affect morbidity or mortality) may wholly or partially
account for the improved 5-year and 10-year survival rates reported.
References
-
Tobkes AI, Nord HJ: Liver biopsy: review of methodology and complications. Dig Dis 13 (5): 267-74, 1995 Sep-Oct.
[PUBMED Abstract]
Back to Top
< Previous Section | Next Section > |